Low intensity light therapy for the manipulation of fibroblast, and fibroblast-derived mammalian cells and collagen
US6676655B2 · kind B2 · utility
251Cited by
37References
24Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Apr 11, 2002 |
| Grant date | Jan 13, 2004 |
| Priority date | — |
| Expiry date | Apr 11, 2022 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61N2005/0652
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Disclosed is a method for treating various dermatalogical conditions using electromagnetic radiation. Particularly preferred are narrowband, multichromatic electromagnetic radiation emitters having a dominant emissive wavelength corresponding to the peak absorption wavelength of the mammalian tissue targetted for treatment. Topical compositions are disclosed for pretreating the targetted tissue to alter the peak absorption wavelength of the tissue.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.